The effect of new chemotherapy before reoperation of accidental gallbladder cancer on the overall prognosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037072

Enrollment

Unknown

Registered

2020-08-26

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unexpected gallbladder carcinoma

Interventions

control group:No neoadjuvant therapy

experimental group:neoadjuvant therapy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with gallbladder cancer were treated with neoadjuvant chemotherapy and those without neoadjuvant chemotherapy; 2. Patients with definite pathology before operation.

Exclusion criteria

Exclusion criteria: Patients without surgical treatment.

Design outcomes

Primary

Measure	Time frame
Overall survival;Disease free survival;Progression free survival;	—

Countries

China

Contacts

Public ContactNi Xiaoling

Zhongshan Hospital Affiliated to Fudan University

ni.xiaoling@zs-hospital.sh.cn+86 13641936840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026